Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
暂无分享,去创建一个
Catharina Lange | Ralph Buchert | Winfried Brenner | Lars Frings | Per Suppa | Lothar Spies | R. Buchert | W. Brenner | L. Spies | L. Frings | P. Suppa | C. Lange
[1] R. Buchert,et al. Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers∗ , 2015, Alzheimer's & dementia.
[2] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[3] et al.,et al. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET , 2002, NeuroImage.
[4] G. Alexander,et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.
[5] Andrea Bergmann,et al. Statistical Parametric Mapping The Analysis Of Functional Brain Images , 2016 .
[6] J. Morris,et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[7] Stewart Young,et al. B-spline-based stereotactical normalization of brain FDG PET scans in suspected neurodegenerative disease: Impact on voxel-based statistical single-subject analysis , 2010, NeuroImage.
[8] Koen Van Laere,et al. EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2 , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[9] Albert Gjedde,et al. Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson’s disease , 2009, NeuroImage.
[10] N Wolfe,et al. Functional Imaging Predicts Cognitive Decline in Alzheimer's Disease , 1996, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[11] Luigi Gianolli,et al. Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting , 2014, NeuroImage: Clinical.
[12] F Fazio,et al. Comparability of FDG PET studies in probable Alzheimer's disease. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] Karl J. Friston,et al. Unified segmentation , 2005, NeuroImage.
[14] C. DeCarli,et al. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. , 2007, Brain : a journal of neurology.
[15] W. Youden,et al. Index for rating diagnostic tests , 1950, Cancer.
[16] D E Kuhl,et al. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. , 1996, Radiology.
[17] Karl J. Friston,et al. Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. , 1998, European journal of nuclear medicine.
[18] William Jagust,et al. Positron emission tomography and magnetic resonance imaging in the diagnosis and prediction of dementia , 2006, Alzheimer's & Dementia.
[19] Harald Hampel,et al. Fully automated atlas-based hippocampal volumetry for detection of Alzheimer's disease in a memory clinic setting. , 2015, Journal of Alzheimer's disease : JAD.
[20] Jesper L. R. Andersson,et al. How to Estimate Global Activity Independent of Changes in Local Activity , 1997, NeuroImage.
[21] N. Foster,et al. Preserved Pontine Glucose Metabolism in Alzheimer Disease: A Reference Region for Functional Brain Image (PET) Analysis , 1995, Journal of computer assisted tomography.
[22] E. Hoffman,et al. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method , 1979, Annals of neurology.
[23] Clifford Goodman,et al. Society of Nuclear Medicine , 1988 .
[24] Karl Herholz,et al. Cerebral glucose metabolism in preclinical and prodromal Alzheimer’s disease , 2010, Expert review of neurotherapeutics.
[25] Manuel Desco,et al. Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls , 2013, Annals of Nuclear Medicine.
[26] Fabrice Crivello,et al. Age- and sex-related effects on the neuroanatomy of healthy elderly , 2005, NeuroImage.
[27] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[28] Manuel Desco,et al. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans , 2003, NeuroImage.
[29] Karl Herholz,et al. Evaluation of a Calibrated 18F-FDG PET Score as a Biomarker for Progression in Alzheimer Disease and Mild Cognitive Impairment , 2011, The Journal of Nuclear Medicine.
[30] Ralph Buchert,et al. Adjusted Scaling of FDG Positron Emission Tomography Images for Statistical Evaluation in Patients With Suspected Alzheimer's Disease , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[31] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[32] Kewei Chen,et al. Summary Metrics to Assess Alzheimer Disease–Related Hypometabolic Pattern with 18F-FDG PET: Head-to-Head Comparison , 2012, The Journal of Nuclear Medicine.
[33] Alexander Hammers,et al. SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging , 2009, NeuroImage.
[34] Alan C. Evans,et al. Searching scale space for activation in PET images , 1996, Human brain mapping.
[35] R H Huesman,et al. Regional Cerebral Metabolic Alterations in Dementia of the Alzheimer Type: Positron Emission Tomography with [1818] Fluorodeoxyglucose , 1983, Journal of computer assisted tomography.
[36] Satoshi Minoshima,et al. Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.
[37] A. Weindl,et al. Voxel-Based Morphometry in Individual Patients: A Pilot Study in Early Huntington Disease , 2009, American Journal of Neuroradiology.
[38] D. Silverman. Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] T. Tasdizen,et al. Realizing the potential of positron emission tomography with 18F-fluorodeoxyglucose to improve the treatment of Alzheimer’s disease , 2008, Alzheimer's & Dementia.
[40] Paul M. Thompson,et al. Characterizing Alzheimer's disease using a hypometabolic convergence index , 2011, NeuroImage.
[41] Nick C Fox,et al. The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .
[42] J. Andersson,et al. Accurate attenuation correction despite movement during PET imaging. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[43] D. J. Wyper,et al. Validation of Statistical Parametric Mapping (SPM) in Assessing Cerebral Lesions: A Simulation Study , 1999, NeuroImage.
[44] G. Frisoni,et al. Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project. , 2015, Journal of Alzheimer's disease : JAD.
[45] Ron Kohavi,et al. A Study of Cross-Validation and Bootstrap for Accuracy Estimation and Model Selection , 1995, IJCAI.
[46] Alexander Hammers,et al. Choice of reference area in studies of Alzheimer's disease using positron emission tomography with fluorodeoxyglucose-F18 , 2008, Psychiatry Research: Neuroimaging.
[47] Karl J. Friston,et al. Human Brain Function , 1997 .
[48] Karl J. Friston,et al. A Standardized [18F]-FDG-PET Template for Spatial Normalization in Statistical Parametric Mapping of Dementia , 2014, Neuroinformatics.
[49] Nick C Fox,et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria , 2014, The Lancet Neurology.
[50] Albert Gjedde,et al. Normalization in PET group comparison studies—The importance of a valid reference region , 2008, NeuroImage.
[51] Javier Arbizu,et al. Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer’s disease dementia , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[52] Harald Hampel,et al. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort. , 2015, Journal of Alzheimer's disease : JAD.
[53] N. Foster,et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.
[54] Paul J. Laurienti,et al. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.
[55] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[56] E. Hoffman,et al. TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD , 1980, Annals of neurology.